Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000506706 | SCV000600806 | uncertain significance | not specified | 2016-12-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002446983 | SCV002680604 | uncertain significance | Hereditary cancer-predisposing syndrome | 2020-02-11 | criteria provided, single submitter | clinical testing | The p.D2819H variant (also known as c.8455G>C), located in coding exon 18 of the BRCA2 gene, results from a G to C substitution at nucleotide position 8455. The aspartic acid at codon 2819 is replaced by histidine, an amino acid with similar properties. This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |